The Journal of Infectious Diseases · 1989 · 198 citations · 43 references
Life SciencesImmunologyMolecular BiologyMolecular EpidemiologyMolecular VirologyVirologyLymphoid NeoplasmsLymphoid TissueLymphoid Tissue PathologyLymphoid TumorsPediatric LymphomasEpstein-barr Virus - Associated Lymphoid NeoplasmsEpstein-barr Virus - Associated MalignanciesEpstein-barr Virus LatencyEpstein-barr Virus PersistenceLymphoma Epidemiology
Epstein-Barr virus (EBV) is associated with lymphomas and lymphoproliferative diseases that occur mainly in immunocompromised patients, but the role EBV plays in their pathogenesis is unclear. The evidence linking EBV etiologically to these disorders includes the presence of EBV DNA and nuclear antigens in the lesions and serologic evidence that some patients with these lesions are experiencing primary or reactivated EBV infections. These syndromes may represent proliferation of cells latently infected with EBV, but the possibility of viral replication has not been rigorously studied. DNA extracted from biopsies of 35 lymphoproliferative diseases was probed with regions of the EBV genome capable of distinguishing circular, episomal DNA found in latency from linear, replicating EBV DNA. All samples contained restriction fragments characteristic of fused termini, indicative of circular, latent genomes. Thirteen samples contained additional restriction fragments diagnostic of linear EBV DNA. Therefore, replicating EBV DNA is found in approximately 40% of EBV-associated lymphoproliferative disorders.
43
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Richard Baer, Alan T. Bankier, Mark D. Biggin et al. · Nature · 1984 · 2.1K citations